These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
168 related items for PubMed ID: 11961131
1. Five amino acids of the Xenopus laevis CRF (corticotropin-releasing factor) type 2 receptor mediate differential binding of CRF ligands in comparison with its human counterpart. Dautzenberg FM, Higelin J, Brauns O, Butscha B, Hauger RL. Mol Pharmacol; 2002 May; 61(5):1132-9. PubMed ID: 11961131 [Abstract] [Full Text] [Related]
2. Binding differences of human and amphibian corticotropin-releasing factor type 1 (CRF(1)) receptors: identification of amino acids mediating high-affinity astressin binding and functional antagonism. Dautzenberg FM, Wille S. Regul Pept; 2004 May 15; 118(3):165-73. PubMed ID: 15003833 [Abstract] [Full Text] [Related]
3. Mapping of the ligand-selective domain of the Xenopus laevis corticotropin-releasing factor receptor 1: implications for the ligand-binding site. Dautzenberg FM, Wille S, Lohmann R, Spiess J. Proc Natl Acad Sci U S A; 1998 Apr 28; 95(9):4941-6. PubMed ID: 9560207 [Abstract] [Full Text] [Related]
4. Different binding modes of amphibian and human corticotropin-releasing factor type 1 and type 2 receptors: evidence for evolutionary differences. Dautzenberg FM, Py-Lang G, Higelin J, Fischer C, Wright MB, Huber G. J Pharmacol Exp Ther; 2001 Jan 28; 296(1):113-20. PubMed ID: 11123370 [Abstract] [Full Text] [Related]
5. Identification of amino acids in the N-terminal domain of corticotropin-releasing factor receptor 1 that are important determinants of high-affinity ligand binding. Wille S, Sydow S, Palchaudhuri MR, Spiess J, Dautzenberg FM. J Neurochem; 1999 Jan 28; 72(1):388-95. PubMed ID: 9886092 [Abstract] [Full Text] [Related]
6. 125I-Antisauvagine-30: a novel and specific high-affinity radioligand for the characterization of corticotropin-releasing factor type 2 receptors. Higelin J, Py-Lang G, Paternoster C, Ellis GJ, Patel A, Dautzenberg FM. Neuropharmacology; 2001 Jan 28; 40(1):114-22. PubMed ID: 11077077 [Abstract] [Full Text] [Related]
10. Structure and function of the ovine type 1 corticotropin releasing factor receptor (CRF1) and a carboxyl-terminal variant. Myers DA, Trinh JV, Myers TR. Mol Cell Endocrinol; 1998 Sep 25; 144(1-2):21-35. PubMed ID: 9863624 [Abstract] [Full Text] [Related]
11. Ligand requirements of the human corticotropin-releasing factor-binding protein. Sutton SW, Behan DP, Lahrichi SL, Kaiser R, Corrigan A, Lowry P, Potter E, Perrin MH, Rivier J, Vale WW. Endocrinology; 1995 Mar 25; 136(3):1097-102. PubMed ID: 7867564 [Abstract] [Full Text] [Related]
12. A single amino acid serves as an affinity switch between the receptor and the binding protein of corticotropin-releasing factor: implications for the design of agonists and antagonists. Eckart K, Jahn O, Radulovic J, Tezval H, van Werven L, Spiess J. Proc Natl Acad Sci U S A; 2001 Sep 25; 98(20):11142-7. PubMed ID: 11572971 [Abstract] [Full Text] [Related]
13. Cloning and functional pharmacology of two corticotropin-releasing factor receptors from a teleost fish. Pohl S, Darlison MG, Clarke WC, Lederis K, Richter D. Eur J Pharmacol; 2001 Nov 02; 430(2-3):193-202. PubMed ID: 11711031 [Abstract] [Full Text] [Related]
17. The alternatively spliced type II corticotropin-releasing factor receptor, stably expressed in LLCPK-1 cells, is not well coupled to the G protein(s). Nabhan C, Xiong Y, Xie LY, Abou-Samra AB. Biochem Biophys Res Commun; 1995 Jul 26; 212(3):1015-21. PubMed ID: 7626087 [Abstract] [Full Text] [Related]
18. Corticotropin-releasing factor receptor type 1 from Tupaia belangeri--cloning, functional expression and tissue distribution. Palchaudhuri MR, Wille S, Mevenkamp G, Spiess J, Fuchs E, Dautzenberg FM. Eur J Biochem; 1998 Nov 15; 258(1):78-84. PubMed ID: 9851694 [Abstract] [Full Text] [Related]